Concretely: 40 mg · 1 mL · 0.9% sodium chloride.
Please show the division. I want to check my own against yours.
I would like the general form as well as the specific number, so I can apply it again.
Is my approach right even if my number is wrong?
The distinction that resolves most of these questions is that bacteriostatic water suppresses microbial growth and does not sterilise anything. It buys you a multiple-withdrawal presentation; it does not make an unsterile preparation sterile, and it does not substitute for technique.
Tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.
| Vial | Diluent | Concentration | 0.25 mg | 0.5 mg | 1 mg | 2.5 mg |
|---|---|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 5 mg | 2 mL | 2.5 mg/mL | 10 u | 20 u | 40 u | 100 u |
| 10 mg | 1 mL | 10 mg/mL | 2.5 u | 5 u | 10 u | 25 u |
| 10 mg | 2 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 10 mg | 3 mL | 3.33 mg/mL | 7.5 u | 15 u | 30 u | 75 u |
Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.
It helps to be literal here: a 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.
The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.
The caveat on all of this is that it assumes the vial contains what the label says.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsIt helps to be literal here: add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.
Photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.
More usefully, the order of operations matters: temperature first, then diluent measurement, then injection, then gentle dissolution, then labeling.
One limitation: technique reduces risk, it does not remove it.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
On the detail: the answer depends on what you want your measurement resolution to be, and that is a real trade-off rather than a preference. More diluent gives you more syringe marks per dose and therefore less rounding error; it also gives you a larger volume to keep cold and a longer period over which the solution has to remain within specification.
On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.
Number of stopper piercings matters less than the gauge doing the piercing.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.
Do the arithmetic twice, ideally with someone else doing it independently.
The underlying point is that the dissolution time is a signal — if it is longer than expected, something went wrong in either the lyophilisation or the shipping.
If the material arrived warm and it was lyophilised, test it and proceed on the result.
Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
The relevant detail is that before anything else: a kitchen counter with an alcohol wipe is not an aseptic environment, and it is worth being honest about that rather than pretending the procedure is something it is not. What you are doing is reducing bioburden, not achieving sterility.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
edited 7 Jun 2026 by RP_C18 — removed a claim I could not source
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.